TY - JOUR
T1 - Immune complexes inhibit IL-1 secretion and inflammasome activation
AU - Janczy, John R.
AU - Ciraci, Ceren
AU - Haasken, Stefanie
AU - Iwakura, Yoichiro
AU - Olivier, Alicia K.
AU - Cassel, Suzanne L.
AU - Sutterwala, Fayyaz S.
N1 - Publisher Copyright:
© 2014 by The American Association of Immunologists, Inc.
PY - 2014/11/15
Y1 - 2014/11/15
N2 - IgG immune complexes have been shown to modify immune responses driven by APCs in either a pro-or anti-inflammatory direction depending upon the context of stimulation. However, the ability of immune complexes to modulate the inflammasomedependent innate immune response is unknown. In this study, we show that IgG immune complexes suppress IL-1α and IL-1β secretion through inhibition of inflammasome activation. The mechanism by which this inhibition occurs is via immune complex ligation of activating FcγRs, resulting in prevention of both activation and assembly of the inflammasome complex in response to nucleotide-binding domain leucine-rich repeat (NLR) P3, NLRC4, or AIM2 agonists. In vivo, administration of Ag in the form of an immune complex during priming of the immune response inhibited resultant adaptive immune responses in an NLRP3-dependent model of allergic airway disease. Our data reveal an unexpected mechanism regulating CD4+ T cell differentiation, by which immune complexes suppress inflammasome activation and the generation of IL-1α and IL-1β from APCs, which are critical for the Ag-driven differentiation of CD4+ T cells.
AB - IgG immune complexes have been shown to modify immune responses driven by APCs in either a pro-or anti-inflammatory direction depending upon the context of stimulation. However, the ability of immune complexes to modulate the inflammasomedependent innate immune response is unknown. In this study, we show that IgG immune complexes suppress IL-1α and IL-1β secretion through inhibition of inflammasome activation. The mechanism by which this inhibition occurs is via immune complex ligation of activating FcγRs, resulting in prevention of both activation and assembly of the inflammasome complex in response to nucleotide-binding domain leucine-rich repeat (NLR) P3, NLRC4, or AIM2 agonists. In vivo, administration of Ag in the form of an immune complex during priming of the immune response inhibited resultant adaptive immune responses in an NLRP3-dependent model of allergic airway disease. Our data reveal an unexpected mechanism regulating CD4+ T cell differentiation, by which immune complexes suppress inflammasome activation and the generation of IL-1α and IL-1β from APCs, which are critical for the Ag-driven differentiation of CD4+ T cells.
UR - http://www.scopus.com/inward/record.url?scp=84910144511&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1400628
DO - 10.4049/jimmunol.1400628
M3 - Article
C2 - 25320279
AN - SCOPUS:84910144511
SN - 0022-1767
VL - 193
SP - 5190
EP - 5198
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -